Leuprolide Acetate Market Trends

  • Report ID: 5156
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Leuprolide Acetate Market Trends

Growth Drivers

  • Rising Demand for IVF Treatment – It is expected that the growing incidence of infertility owing to lifestyle changes, may drive market growth. 
  • Leuprolide acetate injection is a synthetic gonadotropin-releasing hormone that can be used to mature the eggs for retrieval. Moreover, lupron is an injectable fertility drug that is in the category of GnRH agonists which reduces the production of estrogen and progesterone by the ovaries. Over the past five years, IVF cycles have climbed at a pace of over 23%, and India is now ranked third globally for IVF procedures.
  • Growing Geriatric Population- Hormone-related disorders are more common in older people, and the rising elderly population is expected to increase the demand for leuprolide acetate since it is used to manage hormonal imbalances.
  • The number of individuals in the world who are 60 or older will reach over 2 billion by 2050.

Challenges

  • Risk of Potential Side Effects- Leuprolide acetate may cause several side effects such as breast swelling or tenderness, hot flashes, increased bone pain, increased difficulty passing urine, or an aggravation of nerve symptoms, which may hamper the market growth.
  • Stringent Price Control Policies
  • Availability of Alternative Treatments

Leuprolide Acetate Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

6.9%

Base Year Market Size (2023)

USD 2.14 Billion

Forecast Year Market Size (2036)

USD 5.09 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5156
  • Published Date: Jun 28, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of leuprolide acetate is estimated at USD 2.28 Billion.

The leuprolide acetate market size was over USD 2.14 Billion in 2023 and is anticipated to reach USD 5.09 Billion by 2036, witnessing around 6.9% CAGR during the forecast period i.e., between 2024-2036. Growing cases of cancer across the globe and the growing prevalence of uterus fibroids are the major factors driving the growth of the market.

North America industry is predicted to account for the largest share of 40% by 2036, impelled by growing spending in healthcare in the region.

Ferring B.V., Sun Pharmaceutical Industries Ltd., Beijing Biote Pharmaceutical Co., Ltd., Anhui Anke Bioengineering (Group) Co., Ltd., AbbVie Inc., Merck & Co., Inc., Taj Pharmaceuticals Limited., Zydus Group, Cipla Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample